Finland· FI-REL-REL58678
Postafen
A meclozine product containing meclozine dihydrochloride, registered in Finland by Orifarm Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Meclozine is registered in 7 of 19 countries.
Countries holding a registration under ATC R06AE05 (meclozine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Meclozine · ATC R06AE05
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Meclozine dihydrochloride
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- R06AE05
- ATC class
- Meclozine
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa11190010EUR 11.84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
283 interactions on record for meclozine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Meclozine · interactions on record
283 records
- 9 severe
- 269 moderate
- 5 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Meclozine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDRAMAMINE - NMedtech Products Inc.
- NorwayAgyrax2care4 ApS
- SpainNAVICALM 25 MG COMPRIMIDOSArafarma Group S.A.
- IcelandPostafenCampusPharma AB
- SwedenPostafen 25 mg TablettCampus Pharma AB
- FranceAGYRAX, comprimé sécableMEDIXAL
- United KingdomSea-Legs 12.5mg tabletsG.R. Lane Health Products Ltd
- BelgiumAgyrax 25 mgMediXal
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Agyrax, Postafene
- Denmark · Postafen
- Spain · Chiclida
- France · Agyrax, Navidoxine
- United Kingdom (Northern Ireland) · Sea-Legs, Traveleeze
- Greece · Emetostop
- Iceland · Postafen
- Luxembourg · Agyrax, Postafene
- Netherlands · Suprimal
- Norway · Postafen
- Sweden · Postafen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c7b50b6-c002-404a-8621-cb05036fab85 GET /v1/drugs/7c7b50b6-c002-404a-8621-cb05036fab85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "50",
"form": "tabletti",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "25 mg",
"atc_label": "meklotsiini",
"ma_number": "39617",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL58678",
"authorised_at": "2022-02-14"
}See everything about meclozine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.